HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics study for hyperprolactinemia among schizophrenics switched from risperidone to risperidone long-acting injection.

AuthorsYa Mei Bai, Tzu Ting Chen, Wen Kuo Lin, Wen-Ho Chang, Bojian Wu, Chih Hung Hung, Pesus Chou, Jen-Yeu Chen
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 27 Issue 3 Pg. 306-8 (Jun 2007) ISSN: 0271-0749 [Print] United States
PMID17502783 (Publication Type: Clinical Trial, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antipsychotic Agents
  • Risperidone
Topics
  • Administration, Oral
  • Antipsychotic Agents (administration & dosage, adverse effects, pharmacokinetics)
  • Humans
  • Hyperprolactinemia (chemically induced)
  • Injections, Intramuscular
  • Risperidone (administration & dosage, adverse effects, pharmacokinetics)
  • Schizophrenia (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: